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Background:
Angiotensin converting enzyme (ACE) inhibitor toxicity is
infrequently reported and seldom produces significant clinical effects.
Only 15 previous cases of intentional ACE inhibitor overdoses among
adults have been published.1-13  The most commonly observed clinical
effect is hypotension,14 which is typically transitory and responsive
to supportive measures and intravenous hydration.  An additional 48
pediatric exposures were reported in a single case series, none of
which resulted in any adverse effects related to the ACE inhibitors.15
Reversible impairment in renal function has been reported
in 5 cases of ACE inhibitor overdose, but only in association with
systemic hypotension (systolic blood pressure < 90 mmHg).3,5,12,13
We report a case of intentional quinapril overdose where the patient
presented two days later with acute renal failure in the absence of
clinical features of systemic hypotension.  Additionally, this is the
first reported case of quinapril overdose of which we are aware.
Case Report:
A 24-year-old man presented to the Emergency Depart-
ment (ED) with complaints of bilateral flank pain and decreased urine
output for one day.  The patient admitted to intentionally ingesting 40
of his mother’s 5 mg quinapril tablets two days earlier in an attempt to
“get high.”  The patient’s mother confirmed that approximately 40 of
her quinapril tablets were missing.
The patient reported no early adverse effects, but had two
episodes of non-bloody, non-bilious emesis and three loose stools the
following day.  He denied any dizziness, lightheadedness, near-syn-
cope, or other orthostatic symptoms.  On the day of presentation, the
dynamic process.  Furthermore, if waits to see a physician in the
ED, patients should be reassessed continually.  However, this
may be impossible in an ED not provided sufficient nursing staff.
Triage nurses who have responsibility for patients al-
ready triaged and waiting in the waiting room are often unable to
re-evaluate patients simply because they are too busy with new
patients.  By rechecking vital signs and talking with the patient
every two hours, patients should be re-triaged to a higher category
should their conditions deteriorate.  Another issue relates to chang-
ing chief complaints.  In Case #1 the patient’s friend complained
that the patient developed chest pain two hours after arrival, yet
these complaints were not acted upon immediately by the triage
nurse because of overall overcrowding and dividing professional
focus among too many patients.
Sorting out common illness from catastrophic illness
can be difficult.  In Case #2, the patient who presented with head-
ache, fever, and vomiting appeared little different than others with
URI symptoms and appeared appropriate for an “urgent” cat-
egory.  In most triage systems an initial increased respiratory rate
of 24 in the absence of striator would also be categorized as urgent.
It is unclear if the history of trauma would have changed the triage
category to emergent.  In addition, the patient did not receive
repeat vital signs two hours after presentation to the ED.  In Case
#1, the patient’s respiratory rate was 24 and pulse was 116.  If
only EM physicians had been available and not busy with other
patients.  It is possible that a full triage re-assessment at two hours
would have changed the patient’s category to “emergent.”
Triage in the ED is very high-risk, yet does not receive
the attention, funding, or CQI reviews that would reflect its status
as a high-risk activity.  One of the major problems in large hospi-
tals is that the triage nurse is pressured by long lines of patients,
and may perform triage too briefly and too hastily to pick up
subtle signs of high-risk disease.  Questions have also been raised
about the sensitivity and specificity of nurse triage.  In a study
performed at the University of New Mexico, investigators found
that visual triage assessment by physicians significantly increased
sensitivity in identifying those patients who had illnesses result-
ing in admission.5  In the United Kingdom, a five category triage
system has been advocated to increase accuracy in identifying
potentially ill patients.  The rate of under-triage of patients is
unclear, and has not been widely studied.  The Accident in Emer-
gency Department at the Kwong Wah Hospital in Hong Kong
reported a 3.4% instance of under-triage.6  Although this number is
relatively small, when one considers a very large ED with 50,000
patients triaged per year, potentially over 1,500 patients could be
under triaged and sent to the waiting room with potentially serious
and unrecognized conditions.
In conclusion, these two cases illustrate the difficulty of
initial triage, and how disease states may progress rapidly after
triage.  Furthermore, that patients who truly require urgent inter-
vention may not receive timely treatment in overcrowded EDs.
To avoid potential unexpected outcomes, EDs must be provided
with sufficient resources to prevent overcrowding and insure timely
evaluation of all patients by emergency physicians.
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dose.6,8  Furthermore, in the prior cases with renal failure, the clinical and
laboratory evidence of impaired renal function resolved coincident with
correction of systemic hypotension.
 Our patient did not present with systemic hypotension, nor had
he experienced any orthostatic symptoms following his quinapril inges-
tion.  We suggest, therefore, that his renal failure occurred as a result of
decreased glomerular filtration pressure in the absence of systemic hy-
potension.  If this theory is true, our patient appears to be the first victim
of ACE inhibitor overdose to suffer renal failure without a “pre-renal”
cause.  Potential weaknesses in this supposition include lack of docu-
mented blood pressures prior to ED presentation, laboratory confirmation
of the presence of quinapril or its metabolites, or serum angiotensin, aldos-
terone, or ACE activity levels.  Nevertheless, we have no good reason to
doubt the patient’s history of acute quinapril overdose, especially as it was
confirmed by his mother, and no other cause of acute renal failure was
discovered by laboratory and radiographic evaluation.  The patient’s rapid
and apparently complete recovery is most consistent with an acute toxic
injury to the kidney, rather than any intrinsic renal disease.
Conclusion:
Overdoses with quinapril or other ACE inhibitors may occasion-
ally result in renal failure.  This effect is presumably due to reduced glom-
erular filtration pressure from efferent arteriolar dilation, and may occur in
the absence of clinically evident systemic hypotension.
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patient developed intermittent bilateral flank pain without radia-
tion, dysuria, or hematuria.  He had voided a “small amount” of
urine only once in the previous 24 hours.  Past medical history was
significant for schizophrenia for six years, for which he was treated
with clonazepam, olanzapine, and valproic acid.  The patient smoked
and occasionally binged on ethanol, but denied abuse of
psychostimulant and intravenous drugs.
In the ED, vital signs were:  temperature 36.1°C, pulse
96/min, respirations 20/min, blood pressure 158/73 mmHg.  The
patient was a mildly obese, young adult male in no apparent dis-
tress.  Except for moderate bilateral costovertebral angle tender-
ness, physical examination was unremarkable.  Mental status ex-
amination demonstrated full orientation, but poor insight and judge-
ment, and chronic complaints of visual and auditory hallucinations.
Routine serum chemistry evaluation showed:  sodium
131 mEq/L, potassium 4.1 mEq/L, chloride 95 mEq/L, bicarboate
22 mEq/L, BUN 59 mg/dL, creatinine 7.8 mg/dL, glucose 98 mg/dL.
Complete blood count showed:  WBC 10.5 k/mm3, hemoglobin
14.0 g/dl, hematocrit 41.5%, platelets 236 k/mm3.  Urinalysis showed:
specific gravity 1.010, pH 6.0, and 100 mg/dL protein, without
glucose, ketones, nitrite, or any blood cells.  Additional testing
revealed:  serum CPK 174 IU/L, valproic acid 30 µg/mL, and no
detectable amount of ethanol, lithium, salicylate, or acetaminophen.
A urine drugs-of-abuse screen was negative, while a comprehensive
urine drug screen (utilizing thin-layer chromatography, high-pres-
sure liquid chromatography, and gas chromatography – mass spec-
troscopy) was positive only for olanzapine and valproic acid;
quinapril and other ACE inhibitors are not included in this screen.
Chest X-ray and electrocardiogram were unremarkable.
The patient was admitted for acute renal failure.  Renal
ultrasound showed bilateral diffusely increased echotexture, with-
out signs of obstruction or renal stones.  Serum creatinine peaked at
8.3 mg/dL on hospital day 2, and the BUN peaked at 74 mg/dL on
hospital day 3.  Renal biopsy was scheduled, but the patient was
transferred to another institution by his insurer on hospital day 3.
The nephrologists at both institutions agreed that the acute renal
failure was due to quinapril toxicity.  The BUN and creatinine
rapidly improved without hemodialysis, decreasing to 30 and 1.9
mg/dL respectively by discharge on hospital day 5, and therefore
no biopsy was performed.  At telephone follow-up 6 months after
admission, the patient reported no long-term sequelae to his over-
dose.
Discussion:
Renal failure from ACE inhibitor overdose may occur by
causing systemic hypotension and/or by reducing glomerular filtra-
tion pressure.  The proposed mechanism for both effects is de-
creased angiotensin II levels, in the former case affecting the sys-
temic vasculature, and in the latter case resulting in efferent arteri-
olar dilation.  Lending support to this theory are two prior severe
cases of ACE inhibitor overdose-induced hypotension, resistant to
IV volume resuscitation and adrenergic vasopressor agents, which
were successfully treated with angiotensin II infusions:  one case
from enalapril12 and one from lisinopril.13  Therapeutic ACE inhibi-
tor use may also cause renal failure by inducing glomerulonephri-
tis,14 but this has not been reported in overdose situations.
Systemic hypotension has been present in all previously
reported cases of ACE inhibitor overdose-induced renal dysfunc-
tion,3,5,12,13 although hypotension is not universally seen with over-